MyBCTeam

For HER2-negative breast cancer, there are several alternative treatment options to ribociclib (Kisqali). Other CDK4/6 inhibitors include:

• Palbociclib (Ibrance)
• Abemaciclib (Verzenio)

These medications work by interfering with cancer cell division and stopping cells from replicating. Additional treatment options may Show Full Answer

For HER2-negative breast cancer, there are several alternative treatment options to ribociclib (Kisqali). Other CDK4/6 inhibitors include:

• Palbociclib (Ibrance)
• Abemaciclib (Verzenio)

These medications work by interfering with cancer cell division and stopping cells from replicating. Additional treatment options may include:

• Targeted therapies like PARP inhibitors (if you have BRCA1/2 mutations)
• Immunotherapy treatments that help your immune system fight cancer cells
• Antibody-drug conjugates that specifically target breast cancer cells
• Hormone therapy (if your cancer is hormone receptor-positive)

It's important to discuss these alternatives with your healthcare team, as they can recommend the most appropriate option based on your specific cancer type and overall health condition.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

New Treatments for Metastatic Breast Cancer: Extending Life

6 Breast Cancer Treatments: Radiation, Hormones, and More